Treatment patterns among adult patients with asthma: Factors associated with overuse of inhaled β-agonists and underuse of inhaled corticosteroids

Archives of Internal Medicine

Volumn 159, Issue 22, 1999, Pages 2697-2704

  Diette, Gregory B ^a   Wu, Albert W ^a,b   Skinner, Elizabeth A ^b   Markson, Leona ^c   Clark, Rebecca D ^b   McDonald, Robert C ^d   Healy Jr , Joseph P ^e   Huber, Michael ^f   Steinwachs, Donald M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Harvard Pilgrim Health Plan   (United States)

^f Johns Hopkins Univ Sch of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; ASTHMA; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LONGITUDINAL STUDIES; MALE; MANAGED CARE PROGRAMS; MULTIVARIATE ANALYSIS; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; STEROIDS;

EID: 0033611298     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.22.2697     Document Type: Article

References (18)

1. Smith DH, Malone DC, Lawson KA, Okamoto LJ, Battista C, Saunders WB. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med. 1997;156:787-793.
2. Sheffer A, Taggart VS. The National Asthma Education Program: expert panel report guidelines for the diagnosis and management of asthma. Med Care. 1993; 31:MS20-MS28.
3. National Heart, Lung, and Blood Institute. Guidelines tor the Diagnosis and Management of Asthma: Expert Panel Report No. 2. Bethesda, Md: National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051.
4. National Heart, Lung, and Blood Institute. International consensus report on diagnosis and treatment of asthma. Eur Respir J. 1992;5:601-641.
5. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk for hospitalization for asthma. JAMA. 1997;277:887-891.
6. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA. 1992;268:3462-3464.
7. Kerstjens HAM, Brand PLP, Hughes MD, Robinson NJ, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med. 1992;327:1413-1419.
8. Robinson DS, Geddes DM. Inhaled corticosteroids: benefits and risks. J Asthma. 1996;33:5-16.
9. Speizer FE, Doll R, Heaf P, Strang LB. Investigation into use of drugs preceding death from asthma. BMJ. 1968;1:339-343.
10. Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326:501-506.
11. Steinwachs DM, Wu AW, Skinner EA. How will outcomes management work? Health Aff (Millwood). 1994;13:153-162.
12. Steinwachs DM, Wu AW, Skinner EA, Young Y. Asthma Outcomes in Managed Care: Outcomes Management and Quality Improvement: Report Submitted to the Outcomes Management Consortium of the Managed Health Care Association. Baltimore, Md: The Johns Hopkins University; 1996.
13. Inman WHW, Adelstein AM. Rise and fall of asthma mortality in England and Wales in relation to use of pressurized aerosols. Lancet. 1969;2:279-285.
14. Fraser PM, Speizer FE, Waters SDM, Doll R, Mann NM. The circumstances preceding death from asthma in young people in 1968 to 1969. Br J Dis Chest 1971;65:71-84.
15. Suissa S, Ernst P, Boivin JF, et. al. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am J Respir Crit Care Med. 1994;149:604-610.
16. Rand CS, Nides M, Cowles MK, Wise RA, Conet J. Long-term metered-dose inhaler adherence in a clinical trial. Am J Respir Crit Care Med. 1995;152:580-588.
17. Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach. Stat Med. 1994;13:2233-2247.
18. lezzoni LI, ed. Risk Adjustment for Measuring Health Care Outcomes. Ann Arbor, Mich: Health Administration Press; 1994.